Dwight Stapleton, MD, MMM, FACC, FACP, FACPE

Specialties:

Care Provider Overall: 
5
Patient Ratings: 
90
  • Clinical Details
  • Education
  • News & Video
  • Clinical Trials
  • Briefs & Publications
Hospital Privileges: 
  • Guthrie Robert Packer Hospital
Clinical Interests: 
  • Cardiomyopathy
  • Cardiovascular Disease
  • Coronary Heart Disease
  • Dyslipidemia
  • Heart Failure
  • Hypertension
  • Nuclear Cardiology
  • Preventive Cardiology
  • Valvular Heart Disease

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of Recommending Care Provider: 
5
Patients' Confidence in Care Provider: 
5
Time Care Provider Spent with Patient: 
5
Care Provider Spoke Using Clear Language: 
5
Care Provider Efforts to Include in Decisions: 
5
Care Provider's Concern for Questions and Worries: 
5
Care Provider's Explanations of Condition/Problem: 
5
Care Provider Information About Medications: 
5
Care Provider Instructions for Follow-Up Care: 
5
Care Provider's Friendliness and Courtesy: 
5
Residency: 
  • University of Washington School of Medicine, Seattle, Wash.
Certification: 
  • American Board of Internal Medicine
  • American Board of Internal Medicine/Cardiovascular Disease
  • Certification Board of Nuclear Cardiology
  • Level II certification in Cardiovascular Computerized Tomography and Cardiac Magnetic Resonance Imaging
Education: 
  • Yale University School of Medicine, New Haven, Conn.
Internship: 
  • University of Washington School of Medicine, Seattle, Wash.
Fellowship: 
  • University of Washington School of Medicine, Seattle, Wash.
Department: Cardiology
Diagnosis: Cardiac - Hyperlipidemia
Principal Investigator: Stapleton M.D., Dwight
Sponsor: Pfizer
Details (Identifier #): NCT01975376
Title: B1481022: Phase 3 Multi Center, Double Blind, Randomized, Placebo Controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Pf-04950615, In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
Department: Cardiology
Diagnosis: Cardiac - Acute Coronary Syndrome
Principal Investigator: Stapleton M.D., Dwight
Sub-Investigator(s):
  • Depersis, Michael
Sponsor: Sanofi Aventis
Details (Identifier #): NCT01663402
Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome (Odyssey SA_EFC11570)
Department: Cardiology
Diagnosis: Cardiac - Arrhythmia
Principal Investigator: Stapleton M.D., Dwight
Sponsor: Janssen
Details (Identifier #): NCT01877915
Title: A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Oral Rivaroxaban with Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects with Chronic Heart Failure and Significant Coronary Artery Disease Following a Hospitalization for Exacerbation of Heart Failure COMMANDER HF Study

Publications